Pharma-Bio Serv, Inc. (PBSV)

Market Cap	10.31M -29.7%
Revenue (ttm)	9.48M +3.3%
Net Income	251.53K
EPS	0.01
Shares Out	22.90M
PE Ratio	41.00
Forward PE	4.50
Dividend	0.08 (16.67%)
Ex-Dividend Date	Feb 27, 2026

Volume	14,325
Open	0.4500
Previous Close	0.4500
Day's Range	0.4500 - 0.4600
52-Week Range	0.3200 - 0.6500
Beta	0.73
Analysts	n/a
Price Target	n/a
Est. Earnings	Jan 29, 2027

About Pharma-Bio Serv

Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companie...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1993
• Employees: 55
• Stock Exchange: OTCMKTS
• Ticker Symbol: PBSV

Financial Performance

In fiscal year 2025, Pharma-Bio Serv's revenue was $9.00 million, a decrease of -5.34% compared to the previous year's $9.51 million. Losses were -$100,463, -87.08% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 25, 2026

Data Sources Report a data error